Ticker LaunchIPO · BWV
Onconetix, Inc.
Formerly Blue Water Biotech, Inc.; Blue Water Vaccines Inc.
Onconetix, Inc. (BWV) priced its initial public offering on Feb 23, 2022 at $9.00 per share, within its $8.00–$10.00 range, raising $20M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $99.4M. Boustead was lead-left underwriter. Ellenoff Grossman & Schole advised the company and Loeb & Loeb advised the underwriters.
At its 2022 IPO, the company now named Onconetix, Inc. was a biotechnology company developing vaccines to prevent infectious diseases. Its lead program was an influenza vaccine using proprietary technology to identify cross-reactive epitopes.
- Status
- IPO
- Ticker
- BWV
- Exchange
- Nasdaq Capital Market
- Priced
- Feb 23, 2022
- IPO price
- $9.00
- Price range
- $8.00–$10.00
- Raised
- $20M
- Market cap at IPO price
- $99.4M
- First filed
- Oct 8, 2021
- Underwriters
- Boustead
- Company counsel
- Ellenoff Grossman & Schole
- Underwriters' counsel
- Loeb & Loeb
- Sector
- Biotech & pharma
- Country / state
- OH
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Oct 8, 2021
- Latest amendment Feb 8, 2022
- Final prospectus (424B4) Feb 23, 2022
- All filings on EDGAR CIK 1782107
Other Biotech & pharma IPOs in 2022
- AN2 Therapeutics, Inc.ANTX · Mar 28, 2022 · $69M
- Akanda Corp.AKAN · Mar 16, 2022
- Smart for Life, Inc.SMFL · Feb 17, 2022 · $14.4M
- TC BioPharm (Holdings) plcTCBP · Feb 14, 2022
- Nuvectis Pharma, Inc.NVCT · Feb 7, 2022
- Arcellx, Inc.ACLX · Feb 7, 2022 · $123.8M